1.25 by end of march, page-2

One final observation from yesterdays announcement:

".......These recommendations will be considered in the context of Solagran’s overall clinical trials program – and particularly in the light of the results of the yet-to-be-released chronic alcoholics trial. The results of that trial are far more significant than those being revealed today in this announcement."

Now what could be so significant; a cure for drug / alcohol dependency or a cure for chronic depression. Whatever it is the chairman said at last years AGM that these results will make the world sit up and take notice of Ropren. I don't know what it is but it must be important.